Skip to main content
Start of content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at

Previous day publication Next day publication

Minutes of Proceedings

42nd Parliament, 1st Session
Meeting No. 59
Tuesday, June 6, 2017, 10:58 a.m. to 1:01 p.m.
Bill Casey, Chair (Liberal)

• Mel Arnold for Colin Carrie (Conservative)
• Earl Dreeshen for Colin Carrie (Conservative)
• Earl Dreeshen for Rachael Harder (Conservative)
• Raj Grewal for John Oliver (Liberal)
• Raj Saini for Sonia Sidhu (Liberal)
Library of Parliament
• Karin Phillips, Analyst
• Marlisa Tiedemann, Analyst
Canadian Lyme Disease Foundation
• Janet Sperling, Board Member
As an individual
• Sue Faber, Lyme Disease Advocate and Patient
• Jennifer Kravis, Lyme Disease Advocate and Patient
• Vett Lloyd, Professor, Mount Allison University
Pursuant to Standing Order 108(2) and the motion adopted by the Committee on Thursday, May 11, 2017, the Committee commenced its study of the federal framework on Lyme disease.

By unanimous consent, it was agreed, — That, as sponsor of the Federal Framework on Lyme Disease Act (S.C. 2014, c. 37), Elizabeth May, M.P., be allowed to make a short statement.

Vett Lloyd, by videoconference from Sackville, New Brunswick, Janet Sperling, Sue Faber and Jennifer Kravis made statements and answered questions.

At 12:47 p.m., the sitting was suspended.

At 12:49 p.m., the sitting resumed in camera.

The Committee proceeded to the consideration of matters related to Committee business.

It was agreed, — That, regarding the draft work plan in relation to the study of antimicrobial resistance, the witness lists for the first two meetings be adopted.

It was agreed, — That, in relation to the study of the thalidomide survivors contribution program, the draft letter, as amended, be adopted; and that the letter be posted on the Committee’s website.

At 1:01 p.m., the Committee adjourned to the call of the Chair.

David Gagnon
Clerk of the Committee